Abcuro is a Massachusetts-based biotechnology company that researches and develops T-cell-based immunotherapies for the treatment of cancer and autoimmune diseases.
$200M
Feb 11, 2025
-
$180M
Jan 09, 2025
-
Angitia is a China-based clinical-stage biotechnology company that researches and develops novel therapeutics for the treatment of musculoskeletal diseases.
$120M
Dec 10, 2024
-
$400M
Sep 30, 2024
-
Seran is an Oregon-based clinical trial management company that researches and develops formulation development and final dosage forms for the medical sector.
$200M
Sep 16, 2024
-
Frequently Asked Questions about Bain Capital Life Sciences
What is Bain Capital Life Sciences investing in?
Bain Capital Life Sciences has invested in 39 companies including Abcuro, Timberlyne Therapeutics and Angitia
What company did Bain Capital Life Sciences invest in?
Bain Capital Life Sciences invested in a total 39 companies including Abcuro, Timberlyne Therapeutics and Angitia
What are the top 5 investments by Bain Capital Life Sciences?
The top companies in which Bain Capital Life Sciences invested are Abcuro, Timberlyne Therapeutics, Angitia, Kailera Therapeutics and Seran BioScience
